Mylan to sell generic EpiPen amid US costs outcry

Mylan will sell a generic version of its EpiPen at half the price of the branded $600 (€525) emergency allergy shots in coming weeks, bowing to pressure after US politicians derided earlier steps last week as a mere public-relations fix.

The offer by the drugmaker, which has significant facilities across Ireland, to help patients cover out-of-pocket expenses was criticised as insufficient.

It will introduce a generic EpiPen identical to the branded product, which includes the drug itself and the handheld pen with a needle that injects the shot.